Brisbane, CA · Founded 2021 · Privately Held (backing)
Developer of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease. Gate Bioscience is based in Brisbane, CA and was founded in 2021. Its last reported valuation was $161 million in Nov 2025. It has raised $135 million.
Last reported valuation
$161.0M
Oct 2026
Priced at
—
Total raised
$134.5M
Last round
—
Cap table — not yet on record
Gate Bioscience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gate Bioscience with a free account
·Watch Gate Bioscience: the Monday email on marks, rounds and moves
